Interleukin-4 and Interleukin-13 signaling (Homo sapiens)

From WikiPathways

Jump to: navigation, search
26, 369, 726, 7, 17, 28, 32...27, 29, 8638552, 70, 88853838417732, 47, 58, 62, 71...41, 56414, 25, 33, 41, 42779613, 8837, 41, 7741, 778923, 6122, 3512, 46, 57, 6839610, 90118121, 24, 30, 32, 34...1445, 4911571, 8, 16, 18, 19, 32...3, 15, 762, 41398120, 88413831, 3823, 46, 61, 67, 824131, 38cytosolmitochondrial matrixnucleoplasmendoplasmic reticulum lumenHSPA8 MMP2(110-660) IL13-boundtyrosine-phosphorylated IL13 receptor type II with phosphorylated STAT1,STAT3,STAT6TYK2 RORC gene TNFRSF1B TYK2 p-Y1007-JAK2 IL18 gene STAT3-upregulatednuclear proteinsp-Y701-STAT1 ATPJAK1 RHOU gene NDN ADPADPp-Y641-STAT6 FOXO3 IL4 JAK1 p-Y-IL4R FCER2(1-321) IL4R STAT1 gene p-Y705-STAT3 LIF SOCS1 geneIL4BCL6 gene IL13 p-Y705-STAT3 TYK2 FGF2(10-155) STAT3-upregulatedplasma membraneproteinsVEGFA HIF1A BCL2 gene, BCL2L1genep-Y705-STAT3 dimer,p-Y641-STAT6 dimerp-Y641-STAT6 STAT6 p-Y641-STAT6 IL4 IL4R IL1B IL4:p-Y-IL4R:JAK2:p-Y-IL2RG:JAK3:p-Y-JAK1:p-Y705-STAT3,p-Y641-STAT6p-Y705-STAT3 JAK2 ITGAM ANXA1 SOCS5 SOX2 p-Y705-STAT3,p-Y641-STAT6VEGFA gene IL13-downregulatedgenes forextracellularproteinsRORC STAT3-upregulatedgenes for plasmamembrane proteinsIL2RG JAK2 COL1A2 gene IL10 gene IGHE gene BCL2 ANXA1 gene JUNB gene IL12B gene IL6 gene SOCS3 gene IL13:IL13RA:TYK2p-Y701-STAT1 p-Y705-STAT3 TIMP1 PIM1 ZEB1 p-Y641-STAT6 POMC(138-176) ALOX5 gene IL23A gene NOS2 gene p-Y-IL4R JAK3LAMA5 gene IL13RA1ADPTWIST1 p-Y641-STAT6 HGF gene IL17A STAT3-upregulatedextracellularproteinsIL17F S1PR1 IL13-boundtyrosine-phosphorylated IL13R type IIBCL2L1 SOCS3 JAK3 MMP1(84-469) TWIST1 gene IL6R gene MMP1 gene MYC JAK2 POMC gene CCND1 gene VIM p-Y641-STAT6 IL13-upregulatedgenes for plasmamembrane proteinsIL8 gene IL13RA1 STAT3,STAT6TNF(77-233) MAOAIL17A gene IL8 TGFB1 gene IL1A gene Bcl-2/Bcl-X(L)IRF4 HSP90AA1 gene CCL22 gene IL4:IL4R:JAK2:IL13RA1:TYK2p-Y705-STAT3 IL4:IL4R:JAK2:IL13RA:TYK2:SOCS5,(SOCS1)AKT1 gene IL4R JAK1 FOXO1 gene IL4R MUC1 gene CCND1 IL18(1-193) CEBPD p-Y701-STAT1dimer,p-Y705-STAT3dimer,p-Y641-STAT6dimerSTAT3-upregulatedcytosolic proteinsMCL1 gene JAK2 ATPIL4R gene CCL2 JAK2 STAT3-upregulatedgenes forextracellularproteinsGATA3IL13RA1 IL13RA2IL4 IL4 FOXO3 gene STAT6 IL13:IL13RA:TYK2:IL4R:JAK2:JAK1TYK2 p-Y-IL4R TP53 p-Y701-STAT1dimer,p-Y705-STAT3dimer,p-Y641-STAT6dimerMMP9 gene IL18, ALOX5IL13IL13 TNFRSF1B gene ATPIL4,IL13-downregulated extracellular proteinsIL6 FCER2 gene IL6R SOX2 gene MCL1 IGHE FOS gene IL13 IL4RSTAT3 IL4 IL4 VIM gene IL2RG IL4R JAK2BIRC5 gene MMP9 S1PR1 gene TP53 gene JAK3 FSCN1 FSCN1 gene IL13RA2 PTGS2STAT1 SOCS1CCL22(25-93) SOCS1 NDN gene, TP53 geneIL4, IL13STAT1 MYC gene IL1B gene IGHG1 gene STAT6 upregulatedextracellularprotein genesNOS2 IL13-upregulatedproteinsRORA gene OPRM1 IL4,IL13-downregulated genes for extracellular proteinsIL13RA1:TYK2p-Y701-STAT1 FASLG(1-281)JAK2 BIRC5 ALOX15 IL13RA1 STAT6 upregulatedextracellularproteinsp-Y-IL13RA1 OSM HSP90AA1 PIM1 gene AKT1 IL1B gene IL6 NANOG TYK2 STAT3 IGHG4 gene HIF1A gene IL12A gene ITGB1 MMP3(100-477) STAT3 IL12A IL4R p-Y705-STAT3 dimerLIF gene p-Y705-STAT3 IL4,IL13-upregulatedextracellularproteinsp-Y-IL4R STAT3 SAA1(19-122) IL10 HGF(32-494) CCL11 gene IL4,IL13-upregulatedextracellular genesBCL6 CDKN1A gene RHOU p-Y1007-JAK2 ITGB2 PIK3R1 OPRM1 gene JAK1IL4:IL4R:JAK2:IL2RG:JAK3:JAK1IL13 SOCS5,(SOCS1)NDN, TP53OPRD1 gene HSPA8 gene, ALOX15geneJAK3 TNF gene IL23R IL1A gene p-Y641-STAT6 OPRD1 p-Y705-STAT3 dimer,p-Y614-STAT6 dimerJUNB TYK2IL4R p-Y-IL13RA1 F13A1 gene IL13-boundtyrosine-phosphorylated IL13 receptor type II with STAT1,STAT3,STAT6ITGAM gene MAOA geneHSPA8 gene p-Y-IL2RG IGHG1 JAK1 IL4:p-Y-IL4R:JAK2:p-Y-IL2RG:JAK3:p-Y-JAK1:STAT3,STAT6JAK2 PIK3R1 gene CEBPD gene IL18 gene, ALOX5geneHMOX1JAK3 IL23R gene STAT6 IL4:IL4R:JAK2p-Y-IL2RG POU2F1 STAT6 IL6 gene BATF TYK2 TNF(77-233) STAT3-upregulatedgenes for cytosolicproteinsLBP ALOX5 FCER2(1-321) FN1(32-2386) HSP90B1FCER2 gene ALOX15 gene LCN2 gene IL4 p-Y-TYK2 ICAM1 gene IL2RG:JAK3CDKN1A MUC1(24-1255) FOS BCL2 gene IL2RG p-Y-TYK2 IL13RA1 MMP3 gene p-Y-JAK1 p-Y-IL13RA1 IL13:IL13RA:TYK2:IL4R:JAK2IL4R IL17F gene p-Y641-STAT6 CD36 geneIL13 IL13-downregulatedproteinsSOCS5 ATPIL1B,Myr82K-Myr83K-IL1A CCL2 gene MMP2 gene IL4R IL13RA1 p-Y701-STAT1 IL13BATF gene NANOG gene IL4 p-Y-IL4R JAK2 JAK2 STAT6 upregulatedplasma membraneprotein genesOSM gene FN1 gene p-Y-IL2RG HMOX1 geneTIMP1 gene p-Y701-STAT1,p-Y705-STAT3,p-Y641-STAT6JAK2 p-Y1007-JAK2 IL13 IL13:IL13RA2IGHG4 SOCS1 LAMA5 IL12B IRF4 gene POU2F1 gene p-Y641-STAT6 IL2RGIL4:IL4R:JAK2:IL2RG:JAK3IL4:p-Y-IL4R:JAK2:p-Y-IL2RG:JAK3:p-Y-JAK1ITGAX VCAM1 p-Y705-STAT3 JAK2 TNF gene Myr82K-Myr83K-IL1A STAT1 ZEB1 gene IL23A ICAM1 HSPA8, ALOX15JAK3 p-Y705-STAT3 IL13RA1 p-Y-TYK2 CCL11 GATA3 geneLBP gene IL13 factor XIII A chain 4xPalmC-CD36FOXO1 SAA1 gene COL1A2 JAK1 VCAM1 gene STAT6 upregulatedplasma membraneproteinsIL4R:JAK2ADPSTAT3-upregulatedgenes for nuclearproteinsp-Y-JAK1 TGFB1(30-278) PTGS2 geneITGAX gene p-Y-IL4R FGF2 gene NDN gene IL4 STAT1,STAT3,STAT6IL13 JAK3 ITGB1 Gene RORA BCL2L1 gene LCN2 ITGB2 gene p-Y641-STAT6 dimerp-Y705-STAT3 FASLG genep-Y-JAK1 7473


Description

Interleukin-4 (IL4) is a principal regulatory cytokine during the immune response, crucially important in allergy and asthma (Nelms et al. 1999). When resting T cells are antigen-activated and expand in response to Interleukin-2 (IL2), they can differentiate as Type 1 (Th1) or Type 2 (Th2) T helper cells. The outcome is influenced by IL4. Th2 cells secrete IL4, which both stimulates Th2 in an autocrine fashion and acts as a potent B cell growth factor to promote humoral immunity (Nelms et al. 1999).

Interleukin-13 (IL13) is an immunoregulatory cytokine secreted predominantly by activated Th2 cells. It is a key mediator in the pathogenesis of allergic inflammation. IL13 shares many functional properties with IL4, stemming from the fact that they share a common receptor subunit. IL13 receptors are expressed on human B cells, basophils, eosinophils, mast cells, endothelial cells, fibroblasts, monocytes, macrophages, respiratory epithelial cells, and smooth muscle cells, but unlike IL4, not T cells. Thus IL13 does not appear to be important in the initial differentiation of CD4 T cells into Th2 cells, rather it is important in the effector phase of allergic inflammation (Hershey et al. 2003).

IL4 and IL13 induce “alternative activation� of macrophages, inducing an anti-inflammatory phenotype by signaling through IL4R alpha in a STAT6 dependent manner. This signaling plays an important role in the Th2 response, mediating anti-parasitic effects and aiding wound healing (Gordon & Martinez 2010, Loke et al. 2002)

There are two types of IL4 receptor complex (Andrews et al. 2006). Type I IL4R (IL4R1) is predominantly expressed on the surface of hematopoietic cells and consists of IL4R and IL2RG, the common gamma chain. Type II IL4R (IL4R2) is predominantly expressed on the surface of nonhematopoietic cells, it consists of IL4R and IL13RA1 and is also the type II receptor for IL13. (Obiri et al. 1995, Aman et al. 1996, Hilton et al. 1996, Miloux et al. 1997, Zhang et al. 1997). The second receptor for IL13 consists of IL4R and Interleukin-13 receptor alpha 2 (IL13RA2), sometimes called Interleukin-13 binding protein (IL13BP). It has a high affinity receptor for IL13 (Kd = 250 pmol/L) but is not sufficient to render cells responsive to IL13, even in the presence of IL4R (Donaldson et al. 1998). It is reported to exist in soluble form (Zhang et al. 1997) and when overexpressed reduces JAK-STAT signaling (Kawakami et al. 2001). It's function may be to prevent IL13 signalling via the functional IL4R:IL13RA1 receptor. IL13RA2 is overexpressed and enhances cell invasion in some human cancers (Joshi & Puri 2012).

The first step in the formation of IL4R1 (IL4:IL4R:IL2RB) is the binding of IL4 with IL4R (Hoffman et al. 1995, Shen et al. 1996, Hage et al. 1999). This is also the first step in formation of IL4R2 (IL4:IL4R:IL13RA1). After the initial binding of IL4 and IL4R, IL2RB binds (LaPorte et al. 2008), to form IL4R1. Alternatively, IL13RA1 binds, forming IL4R2. In contrast, the type II IL13 complex (IL13R2) forms with IL13 first binding to IL13RA1 followed by recruitment of IL4R (Wang et al. 2009).

Crystal structures of the IL4:IL4R:IL2RG, IL4:IL4R:IL13RA1 and IL13:IL4R:IL13RA1 complexes have been determined (LaPorte et al. 2008). Consistent with these structures, in monocytes IL4R is tyrosine phosphorylated in response to both IL4 and IL13 (Roy et al. 2002, Gordon & Martinez 2010) while IL13RA1 phosphorylation is induced only by IL13 (Roy et al. 2002, LaPorte et al. 2008) and IL2RG phosphorylation is induced only by IL4 (Roy et al. 2002).

Both IL4 receptor complexes signal through Jak/STAT cascades. IL4R is constitutively-associated with JAK2 (Roy et al. 2002) and associates with JAK1 following binding of IL4 (Yin et al. 1994) or IL13 (Roy et al. 2002). IL2RG constitutively associates with JAK3 (Boussiotis et al. 1994, Russell et al. 1994). IL13RA1 constitutively associates with TYK2 (Umeshita-Suyama et al. 2000, Roy et al. 2002, LaPorte et al. 2008, Bhattacharjee et al. 2013).

IL4 binding to IL4R1 leads to phosphorylation of JAK1 (but not JAK2) and STAT6 activation (Takeda et al. 1994, Ratthe et al. 2007, Bhattacharjee et al. 2013).

IL13 binding increases activating tyrosine-99 phosphorylation of IL13RA1 but not that of IL2RG. IL4 binding to IL2RG leads to its tyrosine phosphorylation (Roy et al. 2002). IL13 binding to IL4R2 leads to TYK2 and JAK2 (but not JAK1) phosphorylation (Roy & Cathcart 1998, Roy et al. 2002).

Phosphorylated TYK2 binds and phosphorylates STAT6 and possibly STAT1 (Bhattacharjee et al. 2013).

A second mechanism of signal transduction activated by IL4 and IL13 leads to the insulin receptor substrate (IRS) family (Kelly-Welch et al. 2003). IL4R1 associates with insulin receptor substrate 2 and activates the PI3K/Akt and Ras/MEK/Erk pathways involved in cell proliferation, survival and translational control. IL4R2 does not associate with insulin receptor substrate 2 and consequently the PI3K/Akt and Ras/MEK/Erk pathways are not activated (Busch-Dienstfertig & González-Rodríguez 2013).

View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 6785807
Reactome-version 
Reactome version: 66
Reactome Author 
Reactome Author: Jupe, Steve

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.; ''Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.''; PubMed Europe PMC
  2. Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M, Kuwano M, Nakajima K, Hamasaki N, Izuhara K.; ''Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.''; PubMed Europe PMC
  3. de Vries JE.; ''The role of IL-13 and its receptor in allergy and inflammatory responses.''; PubMed Europe PMC
  4. Rahaman SO, Vogelbaum MA, Haque SJ.; ''Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.''; PubMed Europe PMC
  5. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T.; ''Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.''; PubMed Europe PMC
  6. Han W, Carpenter RL, Cao X, Lo HW.; ''STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3.''; PubMed Europe PMC
  7. Schiavone D, Dewilde S, Vallania F, Turkson J, Di Cunto F, Poli V.; ''The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.''; PubMed Europe PMC
  8. Coffer P, Lutticken C, van Puijenbroek A, Klop-de Jonge M, Horn F, Kruijer W.; ''Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction.''; PubMed Europe PMC
  9. Haviland R, Eschrich S, Bloom G, Ma Y, Minton S, Jove R, Cress WD.; ''Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer.''; PubMed Europe PMC
  10. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell JE.; ''Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions.''; PubMed Europe PMC
  11. Mikita T, Campbell D, Wu P, Williamson K, Schindler U.; ''Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.''; PubMed Europe PMC
  12. Warren WD, Roberts KL, Linehan LA, Berton MT.; ''Regulation of the germline immunoglobulin Cgamma1 promoter by CD40 ligand and IL-4: dual role for tandem NF-kappaB binding sites.''; PubMed Europe PMC
  13. Madamanchi NR, Li S, Patterson C, Runge MS.; ''Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway.''; PubMed Europe PMC
  14. Berry A, Balard P, Coste A, Olagnier D, Lagane C, Authier H, Benoit-Vical F, Lepert JC, Séguéla JP, Magnaval JF, Chambon P, Metzger D, Desvergne B, Wahli W, Auwerx J, Pipy B.; ''IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.''; PubMed Europe PMC
  15. Zurawski G, de Vries JE.; ''Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells.''; PubMed Europe PMC
  16. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.; ''Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.''; PubMed Europe PMC
  17. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H.; ''Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.''; PubMed Europe PMC
  18. Okumura F, Okumura AJ, Matsumoto M, Nakayama KI, Hatakeyama S.; ''TRIM8 regulates Nanog via Hsp90β-mediated nuclear translocation of STAT3 in embryonic stem cells.''; PubMed Europe PMC
  19. Oh HM, Yu CR, Golestaneh N, Amadi-Obi A, Lee YS, Eseonu A, Mahdi RM, Egwuagu CE.; ''STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O Forkhead transcription factors.''; PubMed Europe PMC
  20. Lo HW, Cao X, Zhu H, Ali-Osman F.; ''Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.''; PubMed Europe PMC
  21. Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F.; ''The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins.''; PubMed Europe PMC
  22. Seki Y, Hayashi K, Matsumoto A, Seki N, Tsukada J, Ransom J, Naka T, Kishimoto T, Yoshimura A, Kubo M.; ''Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.''; PubMed Europe PMC
  23. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S.; ''Essential role of Stat6 in IL-4 signalling.''; PubMed Europe PMC
  24. Liu M, Wilson NO, Hibbert JM, Stiles JK.; ''STAT3 regulates MMP3 in heme-induced endothelial cell apoptosis.''; PubMed Europe PMC
  25. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL.; ''Components of a Stat recognition code: evidence for two layers of molecular selectivity.''; PubMed Europe PMC
  26. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE.; ''The IL-4 receptor: signaling mechanisms and biologic functions.''; PubMed Europe PMC
  27. Shen BJ, Hage T, Sebald W.; ''Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein.''; PubMed Europe PMC
  28. Snyder M, Huang XY, Zhang JJ.; ''Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration.''; PubMed Europe PMC
  29. Hoffman RC, Castner BJ, Gerhart M, Gibson MG, Rasmussen BD, March CJ, Weatherbee J, Tsang M, Gustchina A, Schalk-Hihi C.; ''Direct evidence of a heterotrimeric complex of human interleukin-4 with its receptors.''; PubMed Europe PMC
  30. Jung M, Weigert A, Tausendschön M, Mora J, Ören B, Sola A, Hotter G, Muta T, Brüne B.; ''Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth.''; PubMed Europe PMC
  31. Yakubenko VP, Bhattacharjee A, Pluskota E, Cathcart MK.; ''αMβ₂ integrin activation prevents alternative activation of human and murine macrophages and impedes foam cell formation.''; PubMed Europe PMC
  32. Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L, Takahashi H, Sun HW, Kanno Y, Powrie F, O'Shea JJ.; ''Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.''; PubMed Europe PMC
  33. Mikita T, Daniel C, Wu P, Schindler U.; ''Mutational analysis of the STAT6 SH2 domain.''; PubMed Europe PMC
  34. Schaefer A, Unterberger C, Frankenberger M, Lohrum M, Staples KJ, Werner T, Stunnenberg H, Ziegler-Heitbrock L.; ''Mechanism of interferon-gamma mediated down-regulation of interleukin-10 gene expression.''; PubMed Europe PMC
  35. Davey GM, Heath WR, Starr R.; ''SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation.''; PubMed Europe PMC
  36. Hershey GK.; ''IL-13 receptors and signaling pathways: an evolving web.''; PubMed Europe PMC
  37. Roy B, Cathcart MK.; ''Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes.''; PubMed Europe PMC
  38. Chaitidis P, O'Donnell V, Kuban RJ, Bermudez-Fajardo A, Ungethuem U, Kühn H.; ''Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13.''; PubMed Europe PMC
  39. Harrison DA.; ''The Jak/STAT pathway.''; PubMed Europe PMC
  40. Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, Hirano T.; ''STAT3 is required for the gp130-mediated full activation of the c-myc gene.''; PubMed Europe PMC
  41. Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK.; ''IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages.''; PubMed Europe PMC
  42. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL.; ''An interleukin-4-induced transcription factor: IL-4 Stat.''; PubMed Europe PMC
  43. Zhang D, Sun M, Samols D, Kushner I.; ''STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6.''; PubMed Europe PMC
  44. Foshay KM, Gallicano GI.; ''Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate.''; PubMed Europe PMC
  45. Nelson BH, Lord JD, Greenberg PD.; ''Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.''; PubMed Europe PMC
  46. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, Georas SN, Casolaro V, Schleimer RP.; ''Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells.''; PubMed Europe PMC
  47. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, Takaki H, Himeno K, Takaesu G, Kobayashi T, Yoshimura A.; ''Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1.''; PubMed Europe PMC
  48. Bousquet C, Zatelli MC, Melmed S.; ''Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.''; PubMed Europe PMC
  49. Zhu MH, Berry JA, Russell SM, Leonard WJ.; ''Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta.''; PubMed Europe PMC
  50. Reljic R, Wagner SD, Peakman LJ, Fearon DT.; ''Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.''; PubMed Europe PMC
  51. Yang E, Lerner L, Besser D, Darnell JE.; ''Independent and cooperative activation of chromosomal c-fos promoter by STAT3.''; PubMed Europe PMC
  52. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS, Jove R.; ''Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.''; PubMed Europe PMC
  53. Xu MJ, Feng D, Wu H, Wang H, Chan Y, Kolls J, Borregaard N, Porse B, Berger T, Mak TW, Cowland JB, Kong X, Gao B.; ''Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3.''; PubMed Europe PMC
  54. Chen XS, Zhang Y, Wang JS, Li XY, Cheng XK, Zhang Y, Wu NH, Shen YF.; ''Diverse effects of Stat1 on the regulation of hsp90alpha gene under heat shock.''; PubMed Europe PMC
  55. Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY.; ''Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.''; PubMed Europe PMC
  56. Wang IM, Lin H, Goldman SJ, Kobayashi M.; ''STAT-1 is activated by IL-4 and IL-13 in multiple cell types.''; PubMed Europe PMC
  57. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A.; ''Signaling mechanisms, interaction partners, and target genes of STAT6.''; PubMed Europe PMC
  58. Gaemers IC, Vos HL, Volders HH, van der Valk SW, Hilkens J.; ''A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells.''; PubMed Europe PMC
  59. Huang YH, Wu MP, Pan SC, Su WC, Chen YW, Wu LW.; ''STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.''; PubMed Europe PMC
  60. Becker TM, Boyd SC, Mijatov B, Gowrishankar K, Snoyman S, Pupo GM, Scolyer RA, Mann GJ, Kefford RF, Zhang XD, Rizos H.; ''Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor.''; PubMed Europe PMC
  61. Park HJ, So EY, Lee CE.; ''Interferon-gamma-induced factor binding to the interleukin-4-responsive element of CD23b promoter in human tonsillar mononuclear cells: role in transient up-regulation of the interleukin-4-induced CD23b mRNA.''; PubMed Europe PMC
  62. Hamilton KE, Simmons JG, Ding S, Van Landeghem L, Lund PK.; ''Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells.''; PubMed Europe PMC
  63. Hung W, Elliott B.; ''Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells.''; PubMed Europe PMC
  64. Adamson A, Ghoreschi K, Rittler M, Chen Q, Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ, Laurence A.; ''Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene.''; PubMed Europe PMC
  65. Itoh M, Murata T, Suzuki T, Shindoh M, Nakajima K, Imai K, Yoshida K.; ''Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells.''; PubMed Europe PMC
  66. Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, Kujawski M, Kay H, Cress WD, Jove R, Yu H.; ''Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.''; PubMed Europe PMC
  67. Hebenstreit D, Luft P, Schmiedlechner A, Regl G, Frischauf AM, Aberger F, Duschl A, Horejs-Hoeck J.; ''IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site.''; PubMed Europe PMC
  68. Stütz AM, Woisetschläger M.; ''Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.''; PubMed Europe PMC
  69. Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M, Xu LM, Costanzo C, Cheng JQ, Wang LH.; ''Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.''; PubMed Europe PMC
  70. Bhattacharya S, Ray RM, Johnson LR.; ''STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells.''; PubMed Europe PMC
  71. Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, Kortylewski M, Horne D, Somlo G, Forman S, Jove R, Yu H.; ''STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.''; PubMed Europe PMC
  72. Niu G, Wright KL, Ma Y, Wright GM, Huang M, Irby R, Briggs J, Karras J, Cress WD, Pardoll D, Jove R, Chen J, Yu H.; ''Role of Stat3 in regulating p53 expression and function.''; PubMed Europe PMC
  73. Ichinose A, Hendrickson LE, Fujikawa K, Davie EW.; ''Amino acid sequence of the a subunit of human factor XIII.''; PubMed Europe PMC
  74. Tao N, Wagner SJ, Lublin DM.; ''CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails.''; PubMed Europe PMC
  75. Schuringa JJ, Timmer H, Luttickhuizen D, Vellenga E, Kruijer W.; ''c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).''; PubMed Europe PMC
  76. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP.; ''IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells.''; PubMed Europe PMC
  77. Roy B, Bhattacharjee A, Xu B, Ford D, Maizel AL, Cathcart MK.; ''IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.''; PubMed Europe PMC
  78. Hutt JA, O'Rourke JP, DeWille J.; ''Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland.''; PubMed Europe PMC
  79. Wang Z, Zhu S, Shen M, Liu J, Wang M, Li C, Wang Y, Deng A, Mei Q.; ''STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.''; PubMed Europe PMC
  80. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R.; ''Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.''; PubMed Europe PMC
  81. LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC.; ''Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.''; PubMed Europe PMC
  82. Börner C, Wöltje M, Höllt V, Kraus J.; ''STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.''; PubMed Europe PMC
  83. Wu Y, Diab I, Zhang X, Izmailova ES, Zehner ZE.; ''Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89.''; PubMed Europe PMC
  84. Przanowski P, Dabrowski M, Ellert-Miklaszewska A, Kloss M, Mieczkowski J, Kaza B, Ronowicz A, Hu F, Piotrowski A, Kettenmann H, Komorowski J, Kaminska B.; ''The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia.''; PubMed Europe PMC
  85. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P.; ''Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.''; PubMed